Xu Jiecheng, Pan Daogang, Liao Wei, Jia Zhidong, Pan Mingxin, Weng Jun, Han Xu, Li Shao, Li Yang, Liang Kangyan, Zhou Shuqin, Peng Qing, Gao Yi
Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Guangzhou Overseas Chinese Hospital, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Front Bioeng Biotechnol. 2022 Mar 17;10:826093. doi: 10.3389/fbioe.2022.826093. eCollection 2022.
Drug-induced liver injury is one of the main reasons of withdrawals of drugs in postmarketing stages. However, an experimental model(s) which can accurately recapitulates liver functions and reflects the level of drug hepatotoxicity is lack. In this study, we assessed drug hepatotoxicity using a novel three-dimensional hepatic plate-like hydrogel fiber (3D-P) co-culture system. During the 28-days culture period, the liver-specific functions, hepatocyte polarity, sensitivity of drug-induced toxicity of 3D-P co-culture system were evaluated with 2D co-culture, collagen sandwich co-culture, 3D hybrid hydrogel fiber co-culture and human primary hepatocytes as controls. High-content imaging and analysis (HCA) methods were used to explore the hepatotoxicity mechanism of five statins. The 3D-P co-culture system showed enhancing liver-specific functions, cytochrome P450 enzymes (CYPs) metabolic activity and bile excretion, which were considered to result from improved hepatocyte polarity. Three of the statins may cause acute or chronic hepatotoxicity by different mechanisms, such as cholestatic liver injury. Our 3D-P co-culture system is characterized by its biomimetic hepatic plate-like structure, long-term stable liver specificity, and prominent bile secretion function, making it applicable for acute/chronic drug hepatotoxicity assessments.
药物性肝损伤是药物上市后阶段撤市的主要原因之一。然而,目前缺乏一种能够准确模拟肝功能并反映药物肝毒性水平的实验模型。在本研究中,我们使用一种新型的三维肝板样水凝胶纤维(3D-P)共培养系统评估药物肝毒性。在28天的培养期内,以二维共培养、胶原夹心共培养、三维混合水凝胶纤维共培养和人原代肝细胞作为对照,评估3D-P共培养系统的肝脏特异性功能、肝细胞极性以及药物诱导毒性的敏感性。采用高内涵成像与分析(HCA)方法探究5种他汀类药物的肝毒性机制。3D-P共培养系统表现出增强的肝脏特异性功能、细胞色素P450酶(CYPs)代谢活性和胆汁排泄,这被认为是肝细胞极性改善的结果。其中3种他汀类药物可能通过不同机制导致急性或慢性肝毒性,如胆汁淤积性肝损伤。我们的3D-P共培养系统具有仿生肝板样结构、长期稳定的肝脏特异性以及突出的胆汁分泌功能,适用于急性/慢性药物肝毒性评估。